- What are Kidney Stones? By : Aana Hagans
Informative article on Kidney stones. - Prescribing Information For Kidney Disease Far Too Vague, BMJ By : Nephrology News
Prescribing information for healthcare professionals treating patients with kidney disease is too vague, concludes the latest issue of Drug and Therapeutics Bulletin (DTB). - Radiant Medical Trial Shows Promising Results In Preventing Kidney Damage By : Nephrology News
Endovascular therapeutic hypothermia may help prevent radiocontrast nephropathy (RCN), a cause of kidney failure, according to the results of a clinical feasibility trial presented at the recent American Heart Association's Scientific Sessions 2006 in Chicago. - BIDMC's Terry Strom, MD, Honored By American Society Of Nephrology By : Nephrology News
Terry B. Strom, MD, director of the Division of Immunology at Beth Israel Deaconess Medical Center (BIDMC) and Scientific Director of BIDMC's Transplant Center, received the 2006 Homer W. Smith Award from the American Society of Nephrology at their annual meeting last month in San Diego. - Italian Clinical Study Demonstrates Nephros' Mid-Dilution HDF Therapy As Optimal Treatment For Patie By : Nephrology News
Nephros, Inc. (Amex: NEP), announced today the results of a clinical study conducted at the Maggiore Hospital in Lodi, Italy, by Jean Louis Renaux, PhD, Director of Scientific Affairs -- Bellco SPA. The Italian Study investigated the effectiveness of Nephros' proprietary therapy for End Stage Renal Disease, Mid-Dilution Hemodiafiltration ("HDF"), in treating patients with limited vascular access. - Survival Benefit Associated With Adjuvant Androgen Deprivation Therapy Combined With Radiotherapy Fo By : Nephrology News
UroToday.com - Results of prospective randomized trials by the EORTC and RTOG showed that high risk prostate cancer patients treated with radiation therapy plus androgen deprivation exhibit a survival advantage compared with patients treated with radiation therapy alone. - Residual And Recurrent Disease Following Renal Energy Ablative Therapy: A Multi-Institutional Study By : Nephrology News
UroToday.com - Even as the use of ablative strategies for renal masses such as radiofrequency ablation (RFA) and cryoablation has continued to expand, no guidelines have been proposed for patient follow-up based on the risk of the recurrence. - Long-Term Results Of Cryoablation For Renal Cancer And Complex Renal Masses By : Nephrology News
UroToday.com - In situ thermal destruction of renal masses through the creation of lethal cold temperatures has become an acceptable treatment option for patients with incidentally discovered small renal lesions. - Significant Discrepancy Between Clinical And Pathologic Staging In Renal Cell Carcinoma By : Nephrology News
The treatment algorithm for renal cancer is largely based on the accuracy and reliability of radiographic imaging. The value of preoperative radiographic staging is even more important in the follow-up of patients with renal cancer who undergo laparoscopic nephrectomy with morcellation due to the lack of precise pathologic staging. - Winners Of The Second Embrace Journalism Award For Reporting On Urinary Incontinence Are Announced By : Nephrology News
Journalists from The Netherlands and Germany have been recognised as winners of the second Embrace Journalism Award. - NxStage(R) Achieves Milestone With 1,000 Patients Receiving Therapy By : Nephrology News
NxStage Medical, Inc. (Nasdaq: NXTM), announced that over 1,000 patients are now using its NxStage(R) System One(TM) - Tolterodine Extended-Release Does Not Impair Memory In Patients With Overactive Bladder By : Nephrology News
CHRISTCHURCH, NEW ZEALAND - Tolterodine tartrate extended-release or ER (Detrol LAR), 4 mg per day, does not affect recent memory in healthy older patients with overactive bladder, according to data reported today at the 36th Annual Meeting of the International Continence Society (ICS). - Newly Presented Data On VESIcare (R) (solifenacin Succinate) Show Significant Improvements In Urgenc By : Nephrology News
Patients with overactive bladder (OAB) treated with VESIcare(R) (solifenacin succinate) experienced statistically significant reductions in episodes of urgency (the sudden, compelling need to urinate), according to a new study presented today at the 36th Annual Meeting of the International Continence Society. - Promising Treatment For High Risk Kidney Recipients In First Year Post-Transplant By : Nephrology News
High risk kidney transplant patients may have a new treatment option according to data presented at the American Society of Nephrology Annual Meeting. Data from a 12-month, open-label study indicate that sirolimus-based therapy in combination with either tacrolimus (TAC) or cyclosporine (CsA) is efficacious in high immunologic risk renal allograft recipients when initiated as an early-use regimen during the first year post-transplant. - Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range By : Nephrology News
Today, at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition, data was presented for the first time on the initiation of PROCRIT® (Epoetin alfa) therapy 20,000 Units once every two weeks in patients with anemia related to chronic kidney disease (CKD) who are not on dialysis. - Exercise Program For Older Individuals With CKD To Be Tested By Rutgers College Of Nursing Professor By : Nephrology News
The National Institute of Nursing Research at the National Institutes of Health aw - Defining Biochemical Recurrence Of Prostate Cancer After Radical Prostatectomy: A Proposal For A Sta By : Nephrology News
UroToday.com - While an increasing PSA level is an early sign of prostate cancer (CaP) recurrence, varied definitions of biochemical recurrence (BCR) result in differing reports of disease progression rates - Cost Trends For Oncological Renal Surgery: Support For A Laparoscopic Standard Of Care By : Nephrology News
UroToday.com - This report from the University of Michigan affirms the cost-effectiveness of the laparoscopic approach for oncological renal surgery. - Long-Term Androgen-Deprivation Therapy Results In Metabolic Syndrome In Prostate Cancer Patients By : Nephrology News
UroToday.com - According to a report in the August 20, 2006 issue of the Journal of Clinical Oncology, prostate cancer (CaP) patients treated with long-term androgen-deprivation therapy (ADT) are at risk for metabolic syndrome and possibly more cardiovascular events. - Factors Influencing Time To Resume Activity Following Open Radical Prostatectomy Are Identified By : Nephrology News
According to a report by Dr. Herbert Lepor in the October 2006 issue of the Journal of Urology, higher discharge hematocrit and early post-operative Foley catheter removal are two factors strongly associated with resumption of normal activity following radical prostatectomy. - Impact Of Cautery Versus Cautery-Free Preservation Of Neurovascular Bundles On Early Return Of Poten By : Nephrology News
UroToday.com - Look, But Don't Touch. This is the recommendation of this group of researchers who previously reported their initial experience with the cautery-free technique of handling the neurovascular bundle during robotic-assisted laparoscopic prostatectomy. - The Molecular Basis Of Urgency: Regional Difference Of Vanilloid Receptor Expression In The Human Ur By : Nephrology News
UroToday.com - Transient receptor potential vanilloid-1 receptor (TRPV1) is activated by capsaicin, the drug injected subcutaneously by scientists in an attempt to study C fiber sensitization. - Phase II Trial Of Interferon In Combination With Thalidomide For Metastatic Renal Cell Carcinoma By : Nephrology News
UroToday.com - Both thalidomide and a-interferon (IFN) have been utilized as monotherapy in the treatment of patients with metastatic renal cell carcinoma (RCC), each with modest evidence of activity and acceptable toxicity profiles - Second Primary Malignancies Associated With Renal Cell Carcinoma Histological Subtypes By : Nephrology News
UroToday.com - Past studies have suggested that there is a linkage between the development of renal cell carcinoma (RCC) and the incidence of other secondary malignancies, but this remains controversial. - Analysis Of Risk Factors With Special Reference To Preoperative Inguinal Hernia Morbidity And Pelvic By : Nephrology News
UroToday.com - Inguinal hernia (IH) as a complication of radical retropubic prostatectomy (RRP) was first recognized in 1996 by Regan et al who reported a 12 percent incidence within 6 months of RRP. - PSA Testing In Men Who Present With Hematuria By : Nephrology News
UroToday.com - Hematuria is a non-specific symptom mandating an evaluation of the upper and lower urinary tract. Hematuria by itself is not considered a standard indication for PSA testing. - Phase II Trial Of Continuous Low-Dose Oral Cyclophosphamide And Celecoxib For Metastatic Renal Cell By : Nephrology News
UroToday.com - Traditional chemotherapeutic regimens given at high doses in an intermittent fashion have demonstrated little to no activity in the treatment of metastatic renal cell carcinoma (RCC). - Meeting On Frontiers In Painful Bladder Syndrome, Interstitial Cystitis - Report On The NIDDK Intern By : Nephrology News
UroToday.com - The recently concluded NIDDK meeting on Frontiers in Painful Bladder Syndrome / Interstitial Cystitis was extremely successful and well-received. It was chaired by Deborah Erickson, Professor of Urology at the University of Kentucky. - Characterization And Management Of Postoperative Hemorrhage Following Upper Retroperitoneal Laparosc By : Nephrology News
UroToday.com - This is an important manuscript that documents the incidence of postoperative bleeding (overall 0.4%) with upper retroperitoneal laparoscopic surgery (nephrectomy = 3.3%, adrenalectomy = 5.4%, and partial nephrectomy = 9.9%). - Obesity, Diabetes, And Risk Of Prostate Cancer: Results From The Prostate Cancer Prevention Trial By : Nephrology News
UroToday.com - The association between obesity and prostate cancer risk remains controversial. In the October issue of Cancer Epidemiology Biomarkers and Prevention, Gong and colleagues present data obtained from the PCPT which addresses this very issue. - PSA Velocity Over 2 NG/ML Year Pre Diagnosis Independently Predicts Prostate Cancer Mortality In Men By : Nephrology News
UroToday.com - In the past, prostate cancer risk stratification before definitive treatment had been largely based on preoperative serum PSA, Gleason score, clinical stage, and the percent of positive biopsies on biopsy. Recently, PSA velocity before diagnosis has been increasingly implicated in prostate cancer prognosis. - Aravinda Chakravarti, PhD To Speak At ASN Annual Meeting By : Nephrology News
Renowned human geneticist and computational biologist Aravinda Chakravarti, PhD, Director of the McKusick-Nathans Institute and Professor of Medicine at Johns Hopkins University, will present a State-of-the-Art Lecture entitled "Molecular Dissection of Complex Genetic Disease Using the HapMap" during the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego, California. - Elias Zerhouni, MD, Director Of The NIH, To Speak At ASN Annual Meeting By : Nephrology News
Dr. Elias Zerhouni, Director of the National Institutes of Health (NIH), and a leader in the field of radiology, will present a State-of-the-Art Lecture entitled "Kidney Disease Research within the NIH Roadmap: Strategies for the Future" during the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego, California. - Analyzing Urinary Potassium May Improve Patient Outcomes By : Nephrology News
A simple urine test may enable physicians to help improve their patients' overall diet quality, according to a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego. - Children And Chronic Kidney Disease By : Nephrology News
News tips from the 2006 annual meeting of the American Society of Nephrology, Nov. 14 to 19, San Diego.
SEVERITY OF HIGH BLOOD PRESSURE DOES NOT PREDICT EFFECT ON HEART IN CHILDREN - Framingham Score Underestimates Cardiovascular Risk For Dialysis Patients By : Nephrology News
A standard tool for predicting cardiovascular disease (CVD) risk greatly underestimates the true rate of heart disease among patients receiving dialysis for end-stage renal disease (ESRD), reports a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego. - Metabolic Syndrome Predicts Progressive Kidney Disease In African-Americans By : Nephrology News
For African-Americans with high blood pressure, the combination of risk factors known as metabolic syndrome brings an increased risk of worsening kidney disease, reports a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego. - C.E.R.A. Administered Up To Once Every Four Weeks Maintained Stable Hemoglobin Levels In Dialysis Pa By : Nephrology News
Roche's investigational treatment C.E.R.A., administered once every two weeks or once every four weeks, was shown to maintain stable hemoglobin (Hb) levels in dialysis patients who had been taking short-acting, frequently administered epoetin, according to new data from two phase III trials presented today at the 39th Annual Meeting of the American Society of Nephrology in San Diego, CA. - Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range Wit By : Nephrology News
Today, at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition, data was presented for the first time on the initiation of PROCRIT(R) (Epoetin alfa) therapy 20,000 Units once every two weeks in patients with anemia related to chronic kidney disease (CKD) who are not on dialysis. The FDA-approved initiation dose of PROCRIT for this patient population is 50-100 Units/kg three times per week. - Obesity An Advantage In MHD Patients By : Nephrology News
Despite significant improvements in dialysis treatments, currently over 20% of the 350,000 maintenance hemodialysis (MHD) patients in the United States die each year. A study published in Hemodialysis International finds that this high mortality rate may be attributed to malnutrition. - Affymax Presents Preclinical Data On A Hematide(TM)-Related Peptide At The American Society Of Nephr By : Nephrology News
Affymax, Inc. a clinical-stage pharmaceutical company, today announced the presentation of preclinical data on a Hematide(TM)-related peptide at the American Society of Nephrology Renal Week 2006 in San Diego. - Advanced Magnetics Announces Positive Results From Phase III Study Of Ferumoxytol As An Intravenous By : Nephrology News
Advanced Magnetics (Nasdaq: AMAG) today announced positive results from a Phase III clinical trial of ferumoxytol as an intravenous (IV) iron replacement therapeutic that is being presented at the American Society of Nephrology's Renal Week 2006 Annual Meeting in San Diego - Systemic Treatment Before Surgery For Kidney Cancer Prolongs Patients' Survival By : Nephrology News
Preliminary results from a phase II clinical trial have provided the first evidence that people with kidney cancer being treated with bevacizumab and erlotinib [1] before surgery is safe, effective and may prolong patients' survival. - PLC Systems To Show RenalGuard(TM) At Medica 2006 By : Nephrology News
PLC Systems Inc. (Amex: PLC), a company focused on innovative cardiac and vascular medical device-based technologies, announced today that it will demonstrate the RenalGuard System(TM) at Medica 2006, the 38th International Trade Fair with Congress and World Forum for Medicine, November 15-18, 2006 in Dusseldorf, Germany. - Laparoscopic Cytoreductive Nephrectomy: The M. D. Anderson Cancer Center Experience By : Nephrology News
UroToday.com - The value of cytoreductive nephrectomy has been well proven in independent studies done by oncology groups in the United States and Europe. The best method for doing the procedure appears to be laparoscopic if one considers blood loss and length of hospital stay as documented in earlier albeit smaller series from Walther and colleagues at the NCI1 and Gill and colleagues at the Cleveland Clinic2. - Barbagli Describes Series Of Dorsal Buccal Mucosa Grafts In Female Urethral Stricture Disease By : Nephrology News
UroToday.com - There has been recent literature to support the use of dorsally placed buccal mucosa grafts in the treatment of strictures of the female urethra. The father of dorsal buccal onlays in males, Guido Barbagli and his colleagues from Arezzo Italy, reports on a small series of females undergoing dorsal onlay buccal graft urethroplasties. The report is published in the October 2006 issue of the Journal of Urology. - Prevention And Management Of Complications In Urological Laparoscopic Port Site Placement By : Nephrology News
UroToday.com - This is an excellent review article encompassing all aspects of trocar placement and associated complications. Of note, for decades, the placement of the Veress needle and the initial trocar have been "blind" procedures. Particularly anxiety provoking is the placement of the initial bladed trocar as this maneuver is fraught with the potential, albeit rare, for vascular injury and death. - Neobladder Emptying Failure In Men Examined By : Nephrology News
UroToday.com - Neobladder reconstruction is considered a viable option for many patients undergoing cystectomy. While emptying failure and urinary incontinence are possible complications of this procedure, limited information has been published about the incidence, etiology and therapeutic options for these men with "hypercontinence". A recent report by J. Simon, G. Bartsch and colleagues from Ulm, Germany examines this condition. - Scientists Design A PSA-activated Protoxin That Kills Prostate Cancer: Phase I Clinical Trial By : Nephrology News
Prague, Czech Republic: Scientists have found a way of using a protein made by prostate cancer to target and kill the cancer cells themselves. In preliminary studies the new therapy affected only the prostate, without causing damage to other healthy tissues, and now it is being tested in a phase I clinical trial. - Systemic Treatment Before Surgery For Kidney Cancer Prolongs Patients' Survival By : Nephrology News
Prague, Czech Republic: Preliminary results from a phase II clinical trial have provided the first evidence that treating people with kidney cancer with bevacizumab and erlotinib [1] before surgery is safe, effective and may prolong patients' survival. - Scientists Discover Way To Block Growth Of Prostate Cancer Cells By : Nephrology News
Prague, Czech Republic: Scientists have discovered for the first time a specific biochemical pathway by which the sex hormone, androgen, increases levels of harmful chemicals called reactive oxygen species (ROS) in the prostate gland that play a role in the development of prostate cancer. - Scientists Discover Way To Block Growth Of Prostate Cancer Cells By : Nephrology News
Prague, Czech Republic: Scientists have discovered for the first time a specific biochemical pathway by which the sex hormone, androgen, increases levels of harmful chemicals called reactive oxygen species (ROS) in the prostate gland that play a role in the development of prostate cancer. - Gastric Bypass Surgery May Lead To Increased Kidney Stone Risk By : Nephrology News
Patients who have undergone gastric bypass surgery for morbid obesity have increased risk factors for the formation of kidney stones, according to a paper being presented at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego. - Study Reports GYNECARE THERMACHOICE III Helps Most Women With Heavy Periods Return To Normal Or Less By : Nephrology News
Results from a multicenter, prospective clinical trial showed that nine out of 10 women undergoing treatment with GYNECARE THERMACHOICE III Uterine Balloon Therapy System to treat menorrhagia, or heavy menstrual periods, returned to a normal bleeding rate or less. The data were presented earlier this week at the American Association of Gynecologic Laparoscopists meeting in Las Vegas. - Most Americans Unfamiliar With Risks From Chronic Kidney Disease, Survey Finds By : Nephrology News
Despite the fact that chronic kidney disease (CKD) is a progressive disease that impairs kidney function and affects 20 million Americans(1), a recent survey showed that most adults know little or nothing about the symptoms, treatment and prevention of CKD and are unaware of the risks if the disease is undiagnosed and untreated. - Enzyme May Hold Key To New Treatment Of Diabetic Kidney Disease By : Nephrology News
Northwestern University Feinberg School of Medicine researchers have found that an enzyme called ACE2 may hold the potential to treat diabetic kidney disease, the most common form of kidney disease. - First Patient Treated In Bioniche Phase III Refractory Bladder Cancer Trial By : Nephrology News
Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced the entry of the first patient in its Phase III trial for refractory bladder cancer. The patient was treated by Dr. Gary Steinhoff, Dr. Steinhoff Clinical Research, Victoria, British Columbia, Canada. - Increased Hemodialysis May Lead To Greater Survival Rates By : Nephrology News
A study recently published in Hemodialysis International found that more frequent hemodialysis treatments (five or more weekly) can significantly increase the survival rate of patients suffering from irreversible kidney failure. Typical treatment in the U.S. generally involves three sessions weekly. - 3 Year Evaluation Confirms Long Term Safety And Effectiveness Of Renessa(R) Procedure For Female By : Nephrology News
ovasys Medical, Inc., a developer of innovative therapies in women's health, announced today that Saad Juma, M.D., of the Incontinence Research Foundation in Encinitas, California, presented the results of a study on the long term safety and effectiveness of the company's Renessa(R) procedure for the treatment of stress urinary incontinence (SUI) in women. - NICE Recommends Mimpara® (cinacalcet) For The Treatment Of A Serious Complication Of Kidney Disease By : Nephrology News
The National Institute for Health and Clinical Excellence (NICE) has released a positive Final Appraisal Document (FAD) in support of the use of Mimpara® (cinacalcet) for the treatment of severe secondary hyperparathyroidism (SHPT), a serious complication of kidney failure, in patients with end stage renal disease (ESRD) on maintenance dialysis therapy. - Closing The Tract Of Mini-Percutaneous Nephrolithotomy With Gelatine Matrix Hemostatic Sealant By : Nephrology News
UroToday.com - A recent study was performed by U. Nagele and colleagues from Tuebingen, Germany to evaluate the possibility of performing tubeless percutaneous nephrolithotomy utilizing an injection of gelatin matrix hemostatic sealant (FloSeal) to close the tract. The report is published in the September 2006 issue of Urology. - Laparoscopic Transperitoneal Nephrectomy Is Feasible In The First Year Of Life And Is Not Affected By : Nephrology News
UroToday.com - This study by Jesch et al analyzed the feasibility of laparoscopic nephroureterectomy in children younger than 1 year in relation to the size of the respective kidney. - ACE Inhibitors Reduce Kidney Disease Risk In Diabetics With High Blood Pressure By : Nephrology News
In diabetic patients with hypertension, ACE inhibitors reduce the risk of developing diabetes-related kidney disease, independent of their effect in lowering blood pressure, reports a study in the December Journal of the American Society of Nephrology. - Clarifying Effect Of Potassium Chloride On Both Bladder Sensitivity And Filling By : Nephrology News
Philip and colleagues from Cheshire, UK, undertook a double blind, prospective randomized controlled trial of cystometry using normal saline (NS) and 0.3M potassium chloride (KCl) in an attempt to clarify the effect of potassium chloride on both bladder sensitivity and filling. Twenty-three consecutive female patients with irritative bladder symptoms (frequency, urgency, nocturia) underwent consecutive filling cystometrogram using infusions of NS and KCl, the order of which was randomized. - Left Versus Right: Side Doesn't Matter In Laparoscopic Donor Nephrectomy For Renal Transplantation By : Nephrology News
UroToday.com - Traditionally, donor nephrectomy specimens have been harvested from the left side, due to a variety of technical considerations, not the least of which is the fact that the vessels to the kidney are considerably longer on the left and subsequent vascular anastomoses in the recipient are facilitated. - Screening For Prostate Cancer At Low PSA Range: The Impact Of Digital Rectal Examination On Tumor By : Nephrology News
UroToday.com - For prostate cancer (CaP) screening, PSA and digital rectal examination (DRE) potentially detect different grade and stage tumors. DRE may detect more clinically significant, high-grade lesions compared to PSA. On the other hand, PSA may also capture these tumors, suggesting DRE may add little to the screening process. - New Generation Tissue Sealants And Hemostatic Agents: Innovative Urologic Applications By : Nephrology News
UroToday.com - Hemostatic agents and tissue sealants are routinely used to prevent excess blood loss and in reconstruction during surgical repair. Over the past 20 years, a number of hemostatic agents and tissue sealants have been developed and are currently used in various surgical disciplines. Hemostatic agents act to stop bleeding either mechanically or by augmenting the coagulation cascade, where as tissue sealants are products that bind to and close defects in tissue. - Mutant Gene Causes Severe Kidney Disease In Infants - May Be Reversible, If Diagnosed Early By : Nephrology News
Scientists at the University of Michigan Medical School have discovered a previously unknown cause for a severe, early-onset form of kidney disease and renal failure in children: recessive mutations in a gene called phospholipase C epsilon or PLCE1. - Serum Testosterone Associated With The Metabolic Syndrome By : Nephrology News
UroToday.com - At the recent annual meeting of the American Urological Association, Dr. Steven Kaplan of New York added to the accumulating evidence that serum testosterone (T) is associated with the Metabolic Syndrome (METS). - Sural Nerve Grafting In Robotic Laparoscopic Radical Prostatectomy By : Nephrology News
UroToday.com - The authors report their early experience with robotic laparoscopic placement of sural nerve grafts. Previously, others have reported that in selected cases where cavernous nerves cannot be spared as a result of extensive local disease, sural nerve interposition may aid in erectile recovery in some men. - Neuroanatomic Maps For Nerve Sparing Robotic Prostatectomy: Study Describing Importance By : Nephrology News
UroToday.com - The landmark work of Walsh and Donker now more than two decades ago provided the anatomical framework for development of nerve sparing radical prostate surgery. With the widespread use and acceptance of laparoscopic and robotic approaches to the patient with prostate cancer, appreciation of laparoscopic presentation of the cavernous nerves is needed. - Perioperative Quality Of Care Indicators Of Retropubic Laparoscopic And Robotic Prostatectomy By : Nephrology News
UroToday.com - This report attempted to address the important clinical question of which approach for the man with prostate cancer is best. Over a 30 month period (03/03-10/05), 517 men were enrolled into this study evaluating efficacy and tolerability of open retropubic compared with laparoscopic and robotic approaches. - Extraperitoneal Robotic Assisted Radical Prostatectomy By : Nephrology News
UroToday.com - This report demonstrates that excellent surgical results are possible with rapid OR times in the hands of experienced robotic surgeons. The authors reported that over a 27 month period at the University of Rochester Medical Center 375 men underwent robotic assisted radical prostatectomy. Average intra-operative time was just 160 minutes with a mean blood loss of under 200cc's. No open conversions occurred in this series. - There Is No Significant Difference Between On-Demand PDE5-I Vs. PDE5-I As Rehabilitative Treatment By : Nephrology News
UroToday.com - Rehabilitative pharmacologic therapy has been promoted as a potentially useful, available approach to facilitate erection recovery following prostate cancer surgery. This study enrolled patients self-selecting to undergo proactive intervention following such surgery. - Effects Of Testosterone (T) Administration On Prostate Tissues By : Nephrology News
UroToday.com - Dr. Leonard Marks, Culver City, California reported a multicenter randomized clinical trial of the effects of testosterone (T) administration on prostate tissues in 48 patients with androgen decline of aging male (ADAM). - Long Term Results In The Largest Series Of Inflatable Penile Prosthesis By : Nephrology News
UroToday.com - Dr. Steven Wilson and associates reported at the American Urologic Association annual meeting the long term results in the largest series of inflatable penile prosthesis [IPP]. Of nearly 6000 personal cases, 2384 men with first time IPP were reviewed and 10 and 15 year device survival was evaluated. - Progressive Increase Of Lithotripter Output Produces Better In-Vivo Stone Comminution By : Nephrology News
UroToday.com - How best to deliver shock wave lithotripsy remains an ongoing topic of study. What we have learned over the years is that treatment at a slow rate (60 shock waves/minute) is more effective than treatment at a rapid rate (e.g. 100 shock waves/minute). - Increased Risk Of Kidney Stones In Patients Using Drug Prescribed For Migraines And Seizures By : Nephrology News
Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found. - The Vattikuti Institute Prostatectomy. A Single Surgeon Experience Of 1452 Cases By : Nephrology News
UroToday.com - Dr Mani Menon reported his most current robotic prostatectomy data involving 1452 patients. Using his modified technique among this large cohort of men average age 59 years, with mean pre-operative PSA of 5.2 average total OR time was a very rapid 152 minutes with surgical time (less the time for docking of the robot) of only 90 minutes. - Verapamil Versus Saline And Electromotive Drug Administration (EMDA) For Peyronie's Disease By : Nephrology News
UroToday.com - This abstract reported on a randomized placebo controlled trial of Verapamil versus Saline delivered by EMDA for Peyronie's disease. This was a well-conducted trial of 42 men with PD who underwent EMDA using the Physion device from Italy, two times per week at 2.4 mA per treatment for three months. - Male Contraceptive Halts Development Of Sperm By : Nephrology News
Tests on rats have shown that an experimental male contraceptive drug blocks connections to cells which feed the developing sperm - making the male infertile, say American and Italian scientists. As fairly low doses of the drug are needed, no significant side-effects were detected. - Changing Patterns Of Pelvic Lymphadenectomy For Prostate Cancer: Results From CaPSURE By : Nephrology News
UroToday.com - Surgical staging of pelvic lymph nodes for prostate cancer (CaP) is in continuing evolution, reports Dr. Kawakami and CaPSURE colleagues in the October 2006 issue of the Journal of Urology. - Prostate Cancer Progression Into Androgen Independency Is Associated With Alterations In Cell By : Nephrology News
UroToday.com - Androgen withdrawal of LNCaP cells resulted in the establishment of the LNCaP-19 androgen-independent (AI) subline. Dr. Jennbacken and investigators from Goteborg University, Sweden studied the molecular and cellular changes of the LNCaP-19 line to find properties that differ from LNCaP parental cells and that are associated with its AI phenotype. Their report appears in the online version of The Prostate. - Radiant Medical Initiates Clinical Trial Of Therapeutic Cooling For Kidney Protection By : Nephrology News
Radiant Medical, Inc., a private medical technology company focused on the research and development of endovascular therapeutic hypothermia, today announced the initiation of the COOL RCN Trial, a safety and efficacy study of catheter-based cooling in patients undergoing cardiac catheterization who are at risk of developing radiocontrast nephropathy (RCN). - Interstitial Cystitis Treatment? By : Nephrology News
This letter was sent to Medical News Today offering, perhaps, a treatment idea for Interstitial Cystitis - Multi-Center Study Concludes Nephros Mid-Dilution Hemodiafiltration Therapy Achieves Higher By : Nephrology News
Nephros, Inc. (Amex: NEP), announced today that the results of a randomized, multi-site scientific study indicate that the Company's Mid-Dilution Hemodiafiltration (Mid-HDF) therapy, using its OLpur MD 190 filter, offers the advantages of both pre- and post- HDF, and is "the most efficient dialysis procedure for Low-Molecular Weight Protein removal." - National Kidney Foundation Distributes Unique Survivor's Kit For Katrina Survivors By : Nephrology News
The devastation unleashed by Hurricane Katrina caused the death of nearly 2,000 people in the Gulf area, and reminders of the disaster are widespread. For survivors of the storm, the mental and emotional costs continue to exact a toll. Now the National Kidney Foundation (NKF) is reaching out to a special group of Katrina survivors in Louisiana with a uniquely targeted wellness program. - Fosrenol Does Not Further Impact Cognitive Function Deterioration In CKD Stage 5 Patients By : Nephrology News
Newly published cognitive function data from a large, two-year trial published in the November issue of Kidney International report on the effects of chronic kidney disease (CKD) on cognitive function in CKD Stage 5 patients with hyperphosphatemia (high serum phosphorus levels in the blood), who have been treated with phosphate binder therapy. - Erectile Dysfunction Predicts Extension Of Coronary Artery Disease By Angiography In Acute Coronary By : Nephrology News
UroToday.com - The authors of this study point out that erectile dysfunction (ED) and coronary artery disease (CAD) frequently coexist. In this study, they investigated whether the prevalence of ED is related to the extent of CAD in 182 men undergoing coronary angiography for a first acute coronary syndrome (ACS.) . - Fatty Fish Consumption Associated With Decreased Risk Of Renal Cancer In Women By : Nephrology News
UroToday.com - The consumption of fatty fish such as salmon, herring, and mackerel has been associated with a reduction in the incidence of prostate cancer. This has not been previously studied in other urological malignancies - Reflections On A New Artificial Urinary Sphincter By : Nephrology News
UroToday.com - The basic design of the current artificial urinary sphincter (AUS) manufactured by American Medical Systems (AMS 800) has been unchanged since 1983. A 30% surgical revision rate has been reported by some authors which is largely due to continued stress incontinence particularly at times of increased abdominal pressure and after cuff erosion or urethral atrophy secondary to high cuff pressures. - Ureteroceles - SFU 2006 - 37th Biannual Society For Fetal Urology Meeting By : Nephrology News
UroToday.com - The topic of the Society for Fetal urology meeting was "Ureteroceles". After an introduction by Dr. Thomas Kolon, M.D., the first speaker of the day Michael P. Leonard, M.D. from the Children's Hospital of Eastern Ontario dealt with the difficult task of observation and ureteroceles. - Control Of Prostate Cancer By Transrectal HIFU In 227 Patients By : Nephrology News
UroToday.com - High-intensity focused ultrasound (HIFU) is a novel treatment for localized prostate cancer. Dr. Poissonnier and associates from Lyon, France report their outcomes in 227 patients treated with HIFU in the epub version of European Urology. - U.S. Genomics And Lahey Clinic Announce Collaboration To Study The Role Of MicroRNAs By : Nephrology News
U.S. Genomics Inc. and Lahey Clinic announce the signing of a discovery agreement to study the role microRNAs play in the development of urologic cancers. The objective of the collaboration is to develop more accurate prognoses for bladder and prostate cancer patients. The collaboration combines U.S. Genomics' patented Trilogy(R) 2020 platform and Direct(TM) miRNA assay with Lahey Clinic's expertise in the analysis of tumor progression and experience in disease management. - Rockwell Medical Technologies, Inc. Submits SFP Dose-Ranging Study Protocol To FDA By : Nephrology News
Rockwell Medical Technologies, Inc. (Nasdaq: RMTI), a leading, innovative manufacturer and developer of concentrates and specialty pharmaceuticals focused on the end- stage-renal-disease market (ESRD), reported today that it submitted its Soluble Ferric Pyrophosphate (SFP) Dose Ranging Study protocol to the FDA. - Newly Published Cognitive Function Data In Kidney International By : Nephrology News
Newly published data from a large, two-year trial published in the November issue of Kidney International report on the effects of chronic kidney disease (CKD) on cognitive function in CKD Stage 5 patients with hyperphosphatemia (high serum phosphorus levels in the blood), who have been treated with phosphate binder therapy. - ZymoGenetics Begins Phase 1/2 Clinical Trial With IL-21 And Nexavar In Patients With Renal Cell By : Nephrology News
ZymoGenetics, Inc. (Nasdaq: ZGEN) today announced the start of a Phase 1/2 clinical study of Interleukin 21 (IL-21) in combination with Nexavar(R) (sorafenib) in patients with advanced renal cell cancer. The study will evaluate the safety and preliminary anti-tumor activity of IL-21 in combination with Nexavar. - Kidney Health In Copenhagen: ISN Nexus Symposium By : Nephrology News
An eminent group of nephrologists, endocrinologists, cardiologists, and bone specialists met Oct. 12-15, 2006. This auspicious meeting on the bone and the kidney represents a vital step in translating the critical cross-talk between two key regulators of calcium, magnesium, and phosphate metabolism: the bone and the kidney. - Dynamic Contrast-Enhanced Subtraction Magnetic Resonance Imaging In Diagnostics Of Testicular By : Nephrology News
UroToday.com - Magnetic resonance imaging (MRI) is beginning to play a major role in pediatric urology. Current work done by Damien Grattan-Smith and colleagues are assessing renal function based on MRI imaging giving both a functional and crisp anatomical study especially when implementing 3-D reconstruction. - Preliminary Results With A New Artificial Urinary Sphincter For Stress Urinary Incontinence By : Nephrology News
UroToday.com - Hydraulically controlled artificial urinary sphincters (AUSs) have been used in the treatment of stress incontinence for nearly 30 years. The Brantley-Scott AUS was introduced in 1973 and has evolved into the current AMS-800 (American Medical Systems, Inc.) which until recently was the only commercially available device of its kind.
|
